Drug intelligence / Profile preview

triamcinolone acetonide + prilocaine hydrochloride

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Intraarticular, Intradermal, Intralesional, Topical

Overview

A combination medication containing triamcinolone acetonide, a synthetic glucocorticoid corticosteroid with anti-inflammatory properties, and prilocaine hydrochloride, an amide-type local anesthetic. This combination likely provides both anti-inflammatory effects and local anesthesia for procedures such as intra-articular or soft tissue injections.

Other names: prilocaine and triamcinolone acetonide

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on triamcinolone acetonide + prilocaine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on triamcinolone acetonide + prilocaine hydrochloride.

Explore the full profile